Inhibition of monocyte IL-1 production by the anti-inflammatory compound, SK&F 86002

Auron, 1984, Nucleotide sequence of human monocyte interleukin 1 precursor cDNA, 81, 7907

Colotta, 1984, Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte/macrophage lineage, J. Immun., 132, 936, 10.4049/jimmunol.132.2.936

DiMartino, 1987, Pharmacologic characterization of the anti-inflammatory profiles of a new dual inhibitor of lipoxygenase and cyclooxygenase, Agents Actions, 20, 113, 10.1007/BF01965633

Dinarello, 1984, Interleukin-1, Rev. infect. Dis., 6, 51, 10.1093/clinids/6.1.51

Dinarello, 1984, Induction of acute phase reactants by interleukin-1, Adv. Inflamm. Res., 8, 203

Dinarello, 1984, The influence of lipoxygenase inhibitors on the in vitro production of human leukocyte pyrogen and lymphocyte activating factor (IL-1), Int. J. Immunopharmac., 6, 43, 10.1016/0192-0561(84)90033-X

Griswold, 1987, SK&F 86002: a structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid, Biochem. Pharmac., 36, 3463, 10.1016/0006-2952(87)90327-3

Griswold, 1987, Arachidonic acid-induced inflammation: inhibition by dual inhibitor of arachidonic acid metabolism, SK&F 86002, Inflammation, 11, 189, 10.1007/BF00916020

Kampschmidt, 1978, Effect of human monocyte pyrogen in plasma iron, plasma zinc and blood neutrophils in rabbits and rats, 158, 32

Kurt-Jones, 1985, Identification of a membrane-associated interleukin 1 in macrophages, 82, 1204

Lantos, 1984, Anti-inflammatory activity of 5,6-diaryl-2,3-dihydroimidazo[2,1-b]thiazoles. Isomeric 4-pyridyl and 4-substituted phenyl derivatives, J. med. Chem., 27, 72, 10.1021/jm00367a014

Lee, 1987, Effect of Auranofin treatment on aberrant splenic interleukin production in adjuvant arthritic rats, J. Immun., 139, 3268, 10.4049/jimmunol.139.10.3268

Lipsky, 1983, The role of interleukin-1 in human B cell activation: inhibition of B cell proliferation and the generation of immunoglobulin secreting cells by an antibody against human leukocyte pyrogen, J. Immun., 130, 2708, 10.4049/jimmunol.130.6.2708

Luger, 1983, Chemotatic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells, J. Immun., 131, 816, 10.4049/jimmunol.131.2.816

March, 1985, Cloning sequence and expression of two distinct human interleukin-1 complementary DNAs, Nature, 315, 641, 10.1038/315641a0

Mizel, 1982, Interleukin 1 and T cell activation, Immun. Rev., 63, 51, 10.1111/j.1600-065X.1982.tb00411.x

Mizel, 1981, Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte activating factor (IL-1), 78, 2474

Murphy, 1980, Endogenous pyrogen made by rabbit peritoneal exudate cells are identical with lymphocyte-activating factors made by rabbit alveolar macrophages, J. Immun., 124, 2498, 10.4049/jimmunol.124.5.2498

Novogrodsky, 1983, Agents that increase cellular cAMP inhibit production of IL-2, but not its activity, Biochem. biophys. Res. Commun., 114, 93, 10.1016/0006-291X(83)91598-X

Simon, 1985, A modified assay for Interleukin-1, J. Immun. Meth., 84, 85, 10.1016/0022-1759(85)90417-X